CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Photopharmica, developing light sensitive drugs for the prevention and treatment of diseases in the anti-infective and oncology markets photosensitisers, for industrial applications
Company (Alive / Active)
Leeds Innovation Centre
103 Clarendon Road
United Kingdom
| Total Funding | Date of Last Funding | |
|---|---|---|
| Photopharmica | $0M | Dec 1, 2020 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Company | Status | Description | Investors |
|---|---|---|---|
| Watertown, Massachusetts, United States | Alive / Active | Panacos is developing anti-infective products through discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Per the company, Panacos' proprietary discovery technologies are designed to combat resistance by focusing on novel targets in the virus life cycle, including virus maturation and virus fusion. | Login to see details |
| Cambridge, Massachusetts, United States | Dead / Inactive | Peptimmune develops drugs for the treatment of various autoimmune diseases. | Login to see details |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|
